145 results on '"Segovia, José C"'
Search Results
2. Non-Homologous End-Joining Defect in Fanconi Anemia Hematopoietic Cells Exposed to Ionizing Radiation
3. Figure S1 from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
4. Supplementary Table 1 from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
5. Supplementary Information from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
6. Data from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
7. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients
8. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
9. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
10. Lentiviral-mediated Gene Therapy for Adults and Children with Severe Pyruvate Kinase Deficiency: Results from an Ongoing Global Phase 1 Study
11. Lentiviral Gene Therapy for the Correction of Congenital Dyserythropoietic Anemia Type II
12. Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: Interim Results of a Global Phase 1 Study for Adult and Pediatric Patients
13. Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes
14. In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1
15. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice
16. The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
17. Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice
18. Correction of the Energetic Defects in Pyruvate Kinase Deficiency through Genome Editing in Hematopoietic Stem and Progenitor Cells
19. Modelling Congenital Dyserythropoietic Anemia Type II through Gene Editing in Hematopoietic Stem and Progenitor Cells
20. Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients
21. Optimising stable retroviral transduction of primary human synovial fibroblasts
22. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network
23. Advances in the gene therapy of monogenic blood cell diseases
24. Premature aging and cancer development in transgenic mice lacking functional CYLD
25. Advances in the gene therapy of monogenic blood cell diseases.
26. Hematopoietic Engraftment of Fanconi Anemia Patients through 3 Years after Gene Therapy
27. IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
28. Long-term skin regeneration in xenografts from iPSC teratoma-derived human keratinocytes
29. 753. Lentiviral-Mediated Gene Correction of Mobilized Peripheral Blood Progenitors and Repopulating Cells from FA-A Patients
30. Cardiac Bmi1 + cells contribute to myocardial renewal in the murine adult heart
31. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model
32. The NFKB Inducing Kinase Modulates Hematopoiesis During Stress
33. Interacting Resident Epicardium-Derived Fibroblasts and Recruited Bone Marrow Cells Form Myocardial Infarction Scar
34. Brief Report: Reduced Expression of CD18 Leads to the In Vivo Expansion of Hematopoietic Stem Cells in Mouse Bone Marrow
35. Gene Editing of the Human Pklr Gene in Human Hematopoietic Progenitors to Correct Pyruvate Kinase Deficiency
36. Cardiac Bmi1+ cells contribute to myocardial renewal in the murine adult heart.
37. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+cells from Fanconi anemia patients
38. Development of Lentiviral Vectors with Optimized Transcriptional Activity for the Gene Therapy of Patients with Fanconi Anemia
39. Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown
40. The role of the vav promoter in gene therapy: Safer vectors with weaker and stable expression
41. Evolution to Pathogenicity of the Parvovirus Minute Virus of Mice in Immunodeficient Mice Involves Genetic Heterogeneity at the Capsid Domain That Determines Tropism
42. Constitutively Active Akt Induces Ectodermal Defects and Impaired Bone Morphogenetic Protein Signaling
43. Characteristics of Lentiviral Vectors Harboring the Proximal Promoter of the vav Proto-oncogene: A Weak and Efficient Promoter for Gene Therapy
44. Hematopoietic Dysfunction in a Mouse Model for Fanconi Anemia Group D1
45. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes viain vivocell fusion
46. Altered T cell differentiation and Notch signaling induced by the ectopic expression of keratin K10 in the epithelial cells of the thymus
47. Genetic modification of hematopoietic stem cells: recent advances in the gene therapy of inherited diseases
48. Parvovirus Infection Suppresses Long-Term Repopulating Hematopoietic Stem Cells
49. Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells
50. Severe Leukopenia and Dysregulated Erythropoiesis in SCID Mice Persistently Infected with the Parvovirus Minute Virus of Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.